Evidence-Based CDMO & CRO Architecture

ODM Position Of The Plants Manufacturer & Supplier

Pioneering Phytochemical Standardization, Spatial Botanical Potency Mapping, and Scalable Turnkey Manufacturing for Regulated Global Health Markets.

Featured Clinical & Analytical Solutions

Enterprise-grade contract services and validated extraction units available under ODM/OEM execution frameworks.

China Establishment of analysis methods of active ingredients

China Establishment of analysis methods of active ingredient(s) Supplier, Suppliers

View Specifications

Industrial Paradigm: Decoupling "Position Of The Plants" from Botanical Volatility

A rigorous biochemical framework addressing why plant localization, anatomical part selection, and micro-climatic zoning determine global API reproducibility.

Geo-Spatial Authenticity (Daodi)

Traditional pharmacognosy identifies specific geoclimatic intersections ("Daodi") that yield distinct chemical profiles. Our analytical platform validates soil chemistry, UV altitude stress, and temperature gradients to standardize secondary metabolite expressions across international supply chains.

Anatomical Part Differentiation

Concentrations of target alkaloids, saponins, and polyphenols vary dramatically within the anatomical position of the plant—from primary root cortex to apical leaves. Our research establishes exact harvesting ratios, ensuring that bulk active raw material minimizes inactive biomass ballast.

Seasonal Phenology Dynamics

Harvesting 14 days off-peak can degrade therapeutic potency by up to 60%. By mapping phenological development stages against high-performance chromatography data, we establish strict harvest calendars that lock in therapeutic uniformity year over year.

Macro Industry Solutions for Global Procurement Leaders

Overcoming supply chain instability, variable extraction yields, and stringent pharmacopeial compliance across international borders.

Standardized Dossier Support

Global procurement teams face recurring border holds and testing failures due to shifting limits on pesticide residues, heavy metals, and PAHs. MedGence engineers complete Chemistry, Manufacturing, and Controls (CMC) dossiers matching USP, Ph. Eur., and ChP criteria.

Scalable Extraction Economics

Unrefined extraction often suffers from low yields and solvent residues. Our closed-loop pilot plants and dynamic countercurrent extraction processes increase recovery rates of heat-sensitive compounds by 35% while slashing unit operational expenses.

IP Integrity & Strict Confidentiality

Protecting custom formulation know-how is paramount. Operating under strict, non-disclosure-governed entrusted contract research, MedGence guarantees that intellectual property, extraction blueprints, and clinical outcomes remain 100% exclusive to the client.

Quantifiable Enterprise Track Record

A statistical overview of clinical accomplishments, modernized formulations, and industrial scaling over 14+ years.

14+
Years Dedicated to Natural Medicine CRO & CDMO
300+
Phytochemical Researchers & Clinical Scientists
83
Classic TCM Formulas Modernized & Clinically Validated
~400
Single-Herb Standards & Extraction Blueprints Established

Phytochemical Technology Roadmap & Future Outlook

Transitioning from manual agricultural harvesting to molecular-level metabolomic screening and green continuous processing.

Development Phase Technological Focus Core Analytical Mechanism Industrial Value Output
Phase I: Spatial Phenotyping Geo-spatial GIS tracking and soil microbiome correlation Metabolomics & HPTLC Fingerprint Library Precision mapping of the optimal anatomical harvest locations.
Phase II: Green Supercritical Separation Supercritical CO2 and subcritical fluid extraction Real-time Online HPLC Content Monitoring Zero toxic solvent residues; 99% retention of thermolabile bioactives.
Phase III: Biotransformation & Nano-carriers Enzymatic bioconversion of glycosides and liposomal delivery In vitro Caco-2 Permeability & Cellular Assays Multiplies active compound bioavailability in humans by 4x to 8x.
Phase IV: AI Predictive Formulations Machine learning on TCM synergy databases High-throughput In Silico Target Screening Radically accelerates NDA discovery and functional food formulation.

Localized Technical Support & Cross-Border Compliance

Ensuring compliance with US FDA cGMP, European EMA Herbal Monograph, and APAC Regulatory Dossiers.

cGMP / ISO Auditable Architecture

MedGence facilities in Changsha maintain comprehensive Quality Management Systems aligned with 21 CFR Part 111/210/211. Third-party audits, on-site client inspections, and full batch tracing are provided as standard procedure.

Global Clearance & Monograph Harmonization

Every active shipment comes with certificates of analysis covering species verification (DNA barcoding), residual solvents, heavy metals (ICP-MS), and micro-contaminants, preventing customs border detentions.

Direct Scientist-to-Scientist Liaison

Clients avoid communication layers by coordinating directly with lead pharmacologists and formulation engineers who supervise analytical testing, scale-up runs, and regulatory submission paperwork.

Procurement & Technical FAQ

Essential guidance on minimum volumes, quality documentation, method transfer, and IP protection.

What specific factors define the "Position Of The Plants" in botanical manufacturing?
"Position Of The Plants" encompasses both the macro-geographic environment (altitude, soil mineral content, diurnal temperature fluctuation, and Daodi authenticity) and micro-anatomical orientation (roots, rhizomes, inner bark, petiole, leaves, flower buds, or seed pods). Controlling both parameters ensures uniform concentrations of key secondary metabolites.
How does MedGence handle analytical method transfer for novel botanical compounds?
We establish and cross-validate HPLC, GC, and HPTLC protocols adhering to ICH Q2(R1) guidelines, documenting precision, intermediate precision, linearity range, LOD/LOQ, and robustness. The full testing method dossier is transferred to the buyer's quality control laboratory alongside matching chemical reference substances.
What safety and toxicology evaluations are available before clinical stages?
We perform comprehensive non-clinical safety studies, including acute oral toxicity (LD50), 28-day and 90-day subchronic toxicity in rodents, genotoxicity (Ames test, in vitro micronucleus test, chromosomal aberration assay), and local irritation tests for cosmetic-grade botanical actives.
Can MedGence scale clinical trial formulations into finished commercial packaging?
Yes. Our integrated CDMO infrastructure supports small pilot batches for Phase I–IV clinical investigations and seamlessly scales to commercial runs of solid dose units (tablets, capsules, soluble granules) or liquids (oral suspensions, softgels, sublingual tinctures) under strict cGMP environments.
How are client intellectual property and custom formulation recipes secured?
All discovery, analytical development, and OEM manufacturing agreements operate under legally enforceable Non-Disclosure Agreements (NDAs). MedGence functions as an entrusted development and contract manufacturing partner; all generated chromatographic fingerprints, yield parameters, and IP rights remain the property of the client.

Complete Natural Medicine CRO & CDMO Catalog

Connect with our technical desk to commission pilot extraction, analytical validation, or OEM production runs.

China Establishment of analysis methods of active ingredient(s) Supplier

China Establishment of analysis methods of active ingredient(s) Supplier, Suppliers

View Specifications
ODM Study and evaluation of the potency of the botanical active ingredients

ODM Study and evaluation of the potency of the botanical active ingredient(s)

View Specifications
China Screening of the active ingredients of plants Manufacturer

China Screening of the active ingredient(s) of plants Manufacturer, Manufacturers

View Specifications